Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Dogwood Therapeutics, Inc. (DWTX)

Compare
4.0900
+0.3600
+(9.65%)
As of 10:10:04 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
12,227.2480
12,227.2480
5,446.9190
12,315.3090
15,640.9400
Operating Income
-12,227.2480
-12,227.2480
-5,446.9190
-12,315.3090
-15,640.9400
Net Non Operating Interest Income Expense
-92.1920
-92.1920
150.9040
67.4750
5.6720
Other Income Expense
-30.7870
-30.7870
--
--
-325
Pretax Income
-12,350.2270
-12,350.2270
-5,296.0150
-12,247.8340
-15,960.2680
Tax Provision
-0.5030
-0.5030
--
--
--
Net Income Common Stockholders
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Diluted NI Available to Com Stockholders
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Basic EPS
-12.52
--
-7.05
-27.75
-48.00
Diluted EPS
-12.52
--
-7.05
-27.75
-48.00
Basic Average Shares
1,027.7880
--
751.0710
442.8040
333.1720
Diluted Average Shares
1,027.7880
--
751.0710
442.8040
333.1720
Total Operating Income as Reported
-12,227.2480
-12,227.2480
-5,446.9190
-12,315.3090
-15,640.9400
Total Expenses
12,227.2480
12,227.2480
5,446.9190
12,315.3090
15,640.9400
Net Income from Continuing & Discontinued Operation
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Normalized Income
-12,318.9383
-12,318.9383
-5,296.0150
-12,247.8340
-15,960.2680
Interest Income
--
--
150.9040
67.4750
--
Interest Expense
92.1920
92.1920
--
--
--
Net Interest Income
-92.1920
-92.1920
150.9040
67.4750
5.6720
EBIT
-12,258.0350
-12,258.0350
-5,446.9190
-12,315.3090
-15,640.9400
EBITDA
-12,245.8580
-12,245.8580
-5,446.9190
-12,315.3090
-15,640.9400
Reconciled Depreciation
12.1770
12.1770
--
--
--
Net Income from Continuing Operation Net Minority Interest
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Total Unusual Items Excluding Goodwill
-30.7870
-30.7870
--
--
--
Total Unusual Items
-30.7870
-30.7870
--
--
--
Normalized EBITDA
-12,215.0710
-12,215.0710
-5,446.9190
-12,315.3090
-15,640.9400
Tax Rate for Calcs
0
0
--
--
--
Tax Effect of Unusual Items
-0.0013
-0.0013
--
--
--
12/31/2021 - 12/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MURA Mural Oncology plc
2.5450
+5.17%
 
SKYE Skye Bioscience, Inc.
1.5400
-2.53%
 
CDT Conduit Pharmaceuticals Inc.
0.6002
-23.06%
 
THTX Theratechnologies Inc.
2.5480
-0.86%
 
KTTA Pasithea Therapeutics Corp.
1.3750
+0.36%
 
PHIO Phio Pharmaceuticals Corp.
2.8600
+5.93%
 
BCTX BriaCell Therapeutics Corp.
4.3094
-3.77%
 
MTVA MetaVia Inc.
0.6844
-6.54%
 
ELAB PMGC Holdings Inc.
2.4980
-3.18%
 
PRTG Portage Biotech Inc.
8.07
+19.53%